Opaleye Management as of March 31, 2015
Portfolio Holdings for Opaleye Management
Opaleye Management holds 37 positions in its portfolio as reported in the March 2015 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Chimerix (CMRX) | 9.9 | $21M | 565k | 37.69 | |
Cempra | 8.0 | $17M | 500k | 34.31 | |
Ariad Pharmaceuticals | 5.7 | $12M | 1.5M | 8.24 | |
Retrophin | 5.6 | $12M | 500k | 23.96 | |
Clovis Oncology | 4.8 | $10M | 140k | 74.23 | |
AMAG Pharmaceuticals | 4.8 | $10M | 190k | 54.66 | |
Agios Pharmaceuticals (AGIO) | 3.9 | $8.5M | 90k | 94.30 | |
Codexis (CDXS) | 3.6 | $7.9M | 1.7M | 4.56 | |
Geron Corporation (GERN) | 3.2 | $6.9M | 1.8M | 3.77 | |
Medgenics Com New | 3.2 | $6.9M | 850k | 8.06 | |
Ultragenyx Pharmaceutical (RARE) | 3.2 | $6.8M | 110k | 62.09 | |
Supernus Pharmaceuticals (SUPN) | 3.0 | $6.5M | 535k | 12.09 | |
Tetraphase Pharmaceuticals | 3.0 | $6.4M | 175k | 36.64 | |
Insys Therapeutics Com New | 3.0 | $6.4M | 110k | 58.13 | |
MiMedx (MDXG) | 2.8 | $6.1M | 590k | 10.40 | |
Fibrogen (FGEN) | 2.8 | $6.0M | 191k | 31.38 | |
Neurocrine Biosciences (NBIX) | 2.7 | $5.8M | 145k | 39.71 | |
Imprimis Pharmaceuticals Com New | 2.5 | $5.5M | 687k | 7.99 | |
Flamel Technologies Sa Sponsored Adr | 2.5 | $5.4M | 300k | 17.98 | |
Trillium Therapeutics Com New | 2.4 | $5.3M | 260k | 20.23 | |
Ophthotech | 2.3 | $4.9M | 105k | 46.53 | |
Adamas Pharmaceuticals | 2.1 | $4.5M | 255k | 17.49 | |
Kite Pharma | 2.0 | $4.4M | 76k | 57.68 | |
Amarin Corp Sponsored Adr New (AMRN) | 1.9 | $4.1M | 1.8M | 2.34 | |
Axogen (AXGN) | 1.6 | $3.5M | 986k | 3.50 | |
Cara Therapeutics (CARA) | 1.5 | $3.2M | 315k | 10.05 | |
Zs Pharma | 1.5 | $3.2M | 75k | 42.08 | |
Lion Biotechnologies | 1.1 | $2.4M | 200k | 12.11 | |
Accelr8 Technology | 1.1 | $2.3M | 101k | 22.50 | |
Tenax Therapeutics | 0.9 | $2.0M | 606k | 3.26 | |
Evoke Pharma | 0.8 | $1.7M | 245k | 7.05 | |
Macrogenics (MGNX) | 0.7 | $1.6M | 50k | 31.38 | |
BioDelivery Sciences International | 0.7 | $1.5M | 141k | 10.50 | |
Celgene Corp Right 12/31/2030 | 0.7 | $1.5M | 490k | 2.97 | |
Biolinerx Sponsored Adr | 0.2 | $528k | 250k | 2.11 | |
Inspiremd Com New | 0.2 | $400k | 1.3M | 0.32 | |
Tracon Pharmaceuticals | 0.1 | $171k | 12k | 14.05 |